39 Results for "

cessation

" in MedChemExpress (MCE) Product Catalog:
Products (39)

39 Results for "cessation" in MCE Product Catalog:

8
8 Publications Verification
Cat. No.: HY-50001
CAS No.: 341001-38-5
Target:  

Influenza Virus

Research Areas:  

Infection

Nucleozin, a potent inhibitor of influenza A virus infection, induces the formation of nucleoprotein (NP) aggregates and antagonizes its nuclear accumulation, leading to cessation of viral replication. Nucleozin impedes influenza A virus replication in vitro with a nanomolar EC50 .
1
1 Cited Publications
Cat. No.: HY-10019
CAS No.: 249296-44-4
Purity:  99.92%
Synonyms: CP 526555
Target:  

nAChR

Varenicline (CP 526555) is an orally active partial agonist of α4β2 nicotinic acetylcholine receptor (α4β2 nAChR, IC50 = 250 nM), which is the principal mediator of nicotine dependence. Varenicline is also a partial agonist of α6β2 nAChR and a full agonist of α7β2 nAChR. Varenicline blocks the direct agonist effects of nicotine on nAChR while stimulates nAChR in a more moderate way, being widely used as an aid of smoking cessation .
1
1 Cited Publications
Cat. No.: HY-10021
CAS No.: 375815-87-5
Purity:  99.93%
Synonyms: CP 526555-18
Target:  

nAChR ERK p38 MAPK

Research Areas:  

Others Neurological Disease Cancer

Varenicline (CP 526555) is an orally active partial agonist of α4β2 nicotinic acetylcholine receptor (α4β2 nAChR, IC50 = 250 nM), which is the principal mediator of nicotine dependence. Varenicline is also a partial agonist of α6β2 nAChR and a full agonist of α6β2 nAChR. Varenicline blocks the direct agonist effects of nicotine on nAChR while stimulates nAChR in a more moderate way, being widely used as an aid of smoking cessation .
1
1 Cited Publications
Cat. No.: HY-N0175
CAS No.: 485-35-8
Synonyms: Cytisine; Sophorine; Baptitoxine
Cytisinicline (Cytisine) is an alkaloid. Cytisinicline (Cytisine) is a partial agonist of α4β2 nAChRs , and partial to full agonist at β4 containing receptors and α7 receptors . Has been used medically to help with smoking cessation .
1
1 Cited Publications
Cat. No.: HY-B0979
CAS No.: 134-63-4
Synonyms: α-Lobeline hydrochloride; L-Lobeline hydrochloride
Lobeline (α-Lobeline) hydrochloride is a brain-penetrant nicotinic receptor agonist. Lobeline hydrochloride increases dopamine (DA) release by inhibiting DA uptake into synaptic vesicles, and altering presynaptic DA storage. Lobeline hydrochloride is effective in smoking cessation .
1
1 Cited Publications
Cat. No.: HY-100637
CAS No.: 92264-81-8
Purity:  99.91%
Hydroxybupropion is the major active metabolite of Bupropion. Hydroxybupropion is metabolized by CYP2B6. Bupropion is an atypical antidepressant and smoking-cessation agent. Hydroxybupropion inhibits norepinephrine uptake with an IC50 value of 1.7 μM. Hydroxybupropion is also a nACh receptor antagonist .
1
1 Cited Publications
Cat. No.: HY-N8505
CAS No.: 579-21-5
Synonyms: 8,10-Diphenyllobelidione
Lobelanine (8,10-Diphenyllobelidione) is a chemical precursor for the biosynthesis of Lobeline. Lobeline is a partial nicotinic agonist and is used as a smoking cessation agent .
Cat. No.: HY-10020
CAS No.: 230615-23-3
Purity:  98.87%
Synonyms: CP 526555 hydrochloride
Target:  

nAChR

Varenicline (CP 526555) is an orally active partial agonist of α4β2 nicotinic acetylcholine receptor (α4β2 nAChR, IC50 = 250 nM), which is the principal mediator of nicotine dependence. Varenicline is also a partial agonist of α6β2 nAChR and a full agonist of α6β2 nAChR. Varenicline blocks the direct agonist effects of nicotine on nAChR while stimulates nAChR in a more moderate way, being widely used as an aid of smoking cessation .
Cat. No.: HY-14201
CAS No.: 103878-84-8
Purity:  99.95%
Synonyms: Ro 19-6327
Target:  

Monoamine Oxidase

Research Areas:  

Neurological Disease

Lazabemide (Ro 19-6327) is a selective, reversible inhibitor of monoamine oxidase B (MAO-B) (IC50=0.03 μM) but less active for MAO-A (IC50>100 μM). Lazabemide ?inhibits monoamine uptake at high concentrations, the IC50 values are 86 μM, 123 μM and >500 μM for noradrenalin, serotonin and dopamine uptake, respectively. Lazabemide can be used for the research of parkinson and?alzheimer′s disease .
Cat. No.: HY-10019A
CAS No.: 866823-63-4
Purity:  99.21%
Synonyms: CP 526555 dihydrochloride
Target:  

nAChR

Varenicline (CP 526555-18) is an orally active partial agonist of α4β2 nicotinic acetylcholine receptor (α4β2 nAChR, IC50 = 250 nM), which is the principal mediator of nicotine dependence. Varenicline is also a partial agonist of α6β2 nAChR and a full agonist of α7β2 nAChR. Varenicline blocks the direct agonist effects of nicotine on nAChR while stimulates nAChR in a more moderate way, being widely used as an aid of smoking cessation .
Cat. No.: HY-12766S
CAS No.: 1216893-18-3
Purity:  99.28%
Bupropion morpholinol-d6 is the deuterated form of Bupropion morpholinol. Bupropion morpholinol is a major metabolite of Bupropion. Bupropion morpholinol inhibits Dopamine, Norepinephrine transporters and the α4β2 nicotinic receptor in vitro. Bupropion morpholinol contributes to antidepressant and smoking cessation activities .
Cat. No.: HY-N0175R
CAS No.: 485-35-8
Synonyms: Cytisine (Standard); Sophorine (Standard); Baptitoxine (Standard)
Cytisinicline (Standard) is the analytical standard of Cytisinicline. This product is intended for research and analytical applications. Cytisinicline (Cytisine) is an alkaloid. Cytisinicline (Cytisine) is a partial agonist of α4β2 nAChRs , and partial to full agonist at β4 containing receptors and α7 receptors . Has been used medically to help with smoking cessation .
Cat. No.: HY-B1423
CAS No.: 90-69-7
Synonyms: α-Lobeline; L-Lobeline
Lobeline (α-Lobeline) is a brain-penetrant nicotinic receptor agonist. Lobeline increases dopamine (DA) release by inhibiting DA uptake into synaptic vesicles, and altering presynaptic DA storage. Lobeline is effective in smoking cessation .
Cat. No.: HY-12766
CAS No.: 357399-43-0
Purity:  99.66%
Research Areas:  

Neurological Disease

Bupropion morpholinol (Hydroxy Bupropion) is a major metabolite of Bupropion. Bupropion morpholinol inhibits Dopamine, Norepinephrine transporters and the α4β2 nicotinic receptor in vitro. Bupropion morpholinol contributes to antidepressant and smoking cessation activities .
Cat. No.: HY-110241
CAS No.: 292634-27-6
Purity:  99.97%
Target:  

nAChR

Research Areas:  

Neurological Disease

Dianicline dihydrochloride is a α4β2 nicotinic acetylcholine receptor partial agonist, a class of agents that includes varenicline and cytisine for smoking cessation. Dianicline dihydrochloride increases cessation rates in a dose-dependent manner .
Cat. No.: HY-14202
CAS No.: 103878-83-7
Synonyms: Ro 19-6327 hydrochloride
Target:  

Monoamine Oxidase

Research Areas:  

Neurological Disease

Lazabemide hydrochloride (Ro 19-6327 hydrochloride) is a selective, reversible inhibitor of monoamine oxidase B (MAO-B) (IC50=0.03 μM) but less active for MAO-A (IC50>100 μM). Lazabemide  inhibits monoamine uptake at high concentrations, the IC50 values are 86 μM, 123 μM and >500 μM for noradrenalin, serotonin and dopamine uptake, respectively. Lazabemide can be used for the research of parkinson and alzheimer′s disease .
Cat. No.: HY-128420
CAS No.: 134-64-5
Synonyms: α-Lobeline sulfate; L-Lobeline sulfate
Lobeline (α-Lobeline) sulfate is a brain-penetrant nicotinic receptor agonist. Lobeline sulfate increases dopamine (DA) release by inhibiting DA uptake into synaptic vesicles, and altering presynaptic DA storage. Lobeline sulfate is effective in smoking cessation .
Cat. No.: HY-155456
Target:  

Cytochrome P450

Research Areas:  

Metabolic Disease

CD-6 is a flavonoid CYP2A6 inhibitor (IC50: 1.566 μM). CYP2A6 inhibits the metabolism of nicotine to cotinine, resulting in an increase in the amount of nicotine available in the blood, leading to increased smoking behavior. CD-6 mediates CYP2A6 inhibition and can be used in research on smoking cessation or smoking-related diseases .
Cat. No.: HY-10021R
CAS No.: 375815-87-5
Synonyms: CP 526555-18 (Standard)
Varenicline (Tartrate) (Standard) is the analytical standard of Varenicline (Tartrate). This product is intended for research and analytical applications. Varenicline (CP 526555) is an orally active partial agonist of α4β2 nicotinic acetylcholine receptor (α4β2 nAChR, IC50 = 250 nM), which is the principal mediator of nicotine dependence. Varenicline is also a partial agonist of α6β2 nAChR and a full agonist of α6β2 nAChR. Varenicline blocks the direct agonist effects of nicotine on nAChR while stimulates nAChR in a more moderate way, being widely used as an aid of smoking cessation .
Cat. No.: HY-B0979R
CAS No.: 134-63-4
Synonyms: α-Lobeline hydrochloride (Standard); L-Lobeline hydrochloride (Standard)
Lobeline (hydrochloride) (Standard) is the analytical standard of Lobeline (hydrochloride). This product is intended for research and analytical applications. Lobeline (α-Lobeline) hydrochloride is a brain-penetrant nicotinic receptor agonist. Lobeline hydrochloride increases dopamine (DA) release by inhibiting DA uptake into synaptic vesicles, and altering presynaptic DA storage. Lobeline hydrochloride is effective in smoking cessation .